Cargando…

Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis

BACKGROUND: Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. Identifying the factors associated with the treatment delay and total delay would be helpful in the prevention of tuberculosis and in reducing the burden on the health care system. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yazdani-Charati, Jamshid, Rezai, Mohammad Sadegh, Fendereski, Afsane, Mohammadi, Soraya, Alipour, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473378/
https://www.ncbi.nlm.nih.gov/pubmed/28638420
_version_ 1783244282456440832
author Yazdani-Charati, Jamshid
Rezai, Mohammad Sadegh
Fendereski, Afsane
Mohammadi, Soraya
Alipour, Nadia
author_facet Yazdani-Charati, Jamshid
Rezai, Mohammad Sadegh
Fendereski, Afsane
Mohammadi, Soraya
Alipour, Nadia
author_sort Yazdani-Charati, Jamshid
collection PubMed
description BACKGROUND: Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. Identifying the factors associated with the treatment delay and total delay would be helpful in the prevention of tuberculosis and in reducing the burden on the health care system. The objective of this study was to assess the treatment delay and total delay in TB patients and investigate the factors causing these delays. MATERIALS AND METHODS: This was a longitudinal study conducted in 2009–2015. Our study consisted of 1694 TB patients registered in the TB center of Mazandaran province. Data regarding the patients’ demographic characteristics and clinical factors associated with treatment delay and total delay were analyzed. Kaplan Meier plots and log rank tests were used to assess the survival pattern. Cox proportional hazards model for multivariable analysis was discussed. We used mean values and median (Q2) [first quartile (Q1)-third quartile (Q3)] to describe delays. RESULTS: The median treatment delay and total delay were 35 (ranged 23–80) and 36 (ranged 24–82) days, respectively. The mean age of TB patients was 47.40±20.3. No significant association was found between the location of residence, nationality, gender, and type of pulmonary TB patients with treatment delay and total delay. Additionally, age, prison status of patients, HIV test, and contact history had a significant relationship with the treatment delay and total delay (p-value <0.05). It was shown that the median total delay in men patients in the ≤14 year-old age group, imprisoner patients, rural patients, patients who have not received an HIV test, smear negative patients, those who are Iranian, and TB patients whose contact history was unknown was lower than that of others. The highest median treatment delay and total delay was in the >60 age groups, and were 41 and 44 days, respectively. Treatment delay was the same as the total delay except in the place of residence variable; median treatment delay among urban patients was less than that of rural patients. CONCLUSION: According to this study age, prison status of patients, HIV test and contact history had a significant relationship with the treatment delay and total delay (P-value<0.05). Understanding the factors that are closely associated with these delays is essential to effectively control TB and could be helpful in reducing these delays.
format Online
Article
Text
id pubmed-5473378
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-54733782017-06-21 Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis Yazdani-Charati, Jamshid Rezai, Mohammad Sadegh Fendereski, Afsane Mohammadi, Soraya Alipour, Nadia Tanaffos Original Article BACKGROUND: Tuberculosis (TB) remains the leading cause of death among infectious diseases worldwide. Identifying the factors associated with the treatment delay and total delay would be helpful in the prevention of tuberculosis and in reducing the burden on the health care system. The objective of this study was to assess the treatment delay and total delay in TB patients and investigate the factors causing these delays. MATERIALS AND METHODS: This was a longitudinal study conducted in 2009–2015. Our study consisted of 1694 TB patients registered in the TB center of Mazandaran province. Data regarding the patients’ demographic characteristics and clinical factors associated with treatment delay and total delay were analyzed. Kaplan Meier plots and log rank tests were used to assess the survival pattern. Cox proportional hazards model for multivariable analysis was discussed. We used mean values and median (Q2) [first quartile (Q1)-third quartile (Q3)] to describe delays. RESULTS: The median treatment delay and total delay were 35 (ranged 23–80) and 36 (ranged 24–82) days, respectively. The mean age of TB patients was 47.40±20.3. No significant association was found between the location of residence, nationality, gender, and type of pulmonary TB patients with treatment delay and total delay. Additionally, age, prison status of patients, HIV test, and contact history had a significant relationship with the treatment delay and total delay (p-value <0.05). It was shown that the median total delay in men patients in the ≤14 year-old age group, imprisoner patients, rural patients, patients who have not received an HIV test, smear negative patients, those who are Iranian, and TB patients whose contact history was unknown was lower than that of others. The highest median treatment delay and total delay was in the >60 age groups, and were 41 and 44 days, respectively. Treatment delay was the same as the total delay except in the place of residence variable; median treatment delay among urban patients was less than that of rural patients. CONCLUSION: According to this study age, prison status of patients, HIV test and contact history had a significant relationship with the treatment delay and total delay (P-value<0.05). Understanding the factors that are closely associated with these delays is essential to effectively control TB and could be helpful in reducing these delays. National Research Institute of Tuberculosis and Lung Disease 2017 /pmc/articles/PMC5473378/ /pubmed/28638420 Text en Copyright© 2017 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yazdani-Charati, Jamshid
Rezai, Mohammad Sadegh
Fendereski, Afsane
Mohammadi, Soraya
Alipour, Nadia
Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title_full Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title_fullStr Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title_full_unstemmed Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title_short Treatment Delay and Total Delay among Pulmonary Tuberculosis Patients in the North of Iran: Application Survival Data Analysis
title_sort treatment delay and total delay among pulmonary tuberculosis patients in the north of iran: application survival data analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473378/
https://www.ncbi.nlm.nih.gov/pubmed/28638420
work_keys_str_mv AT yazdanicharatijamshid treatmentdelayandtotaldelayamongpulmonarytuberculosispatientsinthenorthofiranapplicationsurvivaldataanalysis
AT rezaimohammadsadegh treatmentdelayandtotaldelayamongpulmonarytuberculosispatientsinthenorthofiranapplicationsurvivaldataanalysis
AT fendereskiafsane treatmentdelayandtotaldelayamongpulmonarytuberculosispatientsinthenorthofiranapplicationsurvivaldataanalysis
AT mohammadisoraya treatmentdelayandtotaldelayamongpulmonarytuberculosispatientsinthenorthofiranapplicationsurvivaldataanalysis
AT alipournadia treatmentdelayandtotaldelayamongpulmonarytuberculosispatientsinthenorthofiranapplicationsurvivaldataanalysis